Compare Charles River Laboratories Intl. Inc (CRL) vs iShares Gold Trust (IAU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs iShares Gold Trust — how do they compare? Charles River Laboratories Intl. Inc trades at $228.09 (market cap $11.14B), while iShares Gold Trust trades at $76.35. The key difference: Charles River Laboratories Intl. Inc is trading nearer its 52-week high, iShares Gold Trust nearer its low. Which is the better fit depends on your goals.
| CRL | IAU | |
|---|---|---|
Market Cap | $11.14B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $233.60 | $101.57 |
52-Week Low | $145.57 | $61.62 |
Enterprise Value | $14.00B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $229.75, down 1.57% on the day, near its consensus price target of $229.80. The stock shows a bullish technical trend with strong moving average signals and support at $225. Fundamentally, CRL has beaten EPS estimates for three consecutive quarters but reported a net loss of $144.34 million in 2025, with negative profit margins. Recent news highlights collaborations in AI and NGS services, supporting growth prospects.
Outlook remains mixed: analyst consensus is strongly bullish with 72% buy ratings and a high target of $260, but profitability challenges and high P/E of 684.85 pose risks. Cash flow stability and strategic partnerships offer upside, while margin pressures and debt levels require monitoring for sustained recovery.
IAU, the iShares Gold Trust ETF, is trading at $75.25, down 2.6% with a bearish technical outlook. The ETF faces pressure from rising Treasury yields and Federal Reserve policy uncertainty, though recent weaker CPI data provided temporary support. Gold remains a key asset amid geopolitical tensions and central bank accumulation, with the fund offering low-cost exposure to physical gold.
The outlook for IAU is mixed, balancing strong long-term fundamentals against near-term headwinds. Gold's role as a hedge and central bank demand provide support, but Fed policy and dollar strength pose risks. The ETF's structure offers efficient gold access, but price volatility requires careful position sizing.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About iShares Gold Trust
IAU is a physically backed ETF that seeks to reflect the performance of the price of gold. It provides a convenient and liquid way for investors to include gold in their portfolios as a potential hedge.
Read more on IAU →
